Patents Assigned to Cellfactors PLC
  • Chondrocyte cell-lines
    Patent number: 6841151
    Abstract: The invention relates to chondrocytes and chondrocyte cell-lines for use especially in studying arthritic conditions and also for developing skeletal tissue for use in repair and/or replacement surgery, and the use of articular chondrocyte cell-lines which mineralize calcium to determine potentially beneficial therapeutic agents, and the means for producing such cell-lines, use of hypertrophic chondrocyte cell-lines to produce matrix tissue, and means of producing hypertrophic chondrocyte cell-lines.
    Type: Grant
    Filed: September 5, 2002
    Date of Patent: January 11, 2005
    Assignee: Cellfactors PLC
    Inventor: Bradley Michael John Stringer
  • Neural cultures
    Patent number: 6602708
    Abstract: Production of fully differentiated, optionally immortalized, neural cells—by enhancing replication then inducing differentiation by mimicking cell's natural environment in vitro. The cells are useful for transplantation or drug screening.
    Type: Grant
    Filed: December 6, 1999
    Date of Patent: August 5, 2003
    Assignee: CellFactors plc
    Inventor: Bradley Michael John Stringer
  • Human cell lines
    Patent number: 6340592
    Abstract: The invention relates to a method for producing human cell lines and cell and cell-lines produced by such a method. The method comprising the use of precursor or undifferentiated cells treated with an immortalising agent which is susceptible to environmental conditions so as to provide for selective activation/deactivation of said immortalising agent and so selective activation of differentiation.
    Type: Grant
    Filed: October 23, 2000
    Date of Patent: January 22, 2002
    Assignee: CellFactors plc
    Inventor: Bradley Michael John Stringer
  • Human cell-lines
    Patent number: 6197585
    Abstract: The invention relates to a method for producing human cell lines and cell and cell-lines produced by such a method. The method comprising the use of precursor or undifferentiated cells treated with an immortalising agent which is susceptible to environmental conditions so as to provide for selective activation/deactivation of said immortalising agent and so selective activation of differentiation.
    Type: Grant
    Filed: September 3, 1999
    Date of Patent: March 6, 2001
    Assignee: CellFactors plc
    Inventor: Bradley Michael John Stringer